Telomerase activation by genomic rearrangements in high-risk neuroblastomaMartin Peifer, Johannes H. Schulte, Andrea Krämer et al.|Nature|2015Cited by 608
Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancerMartin L. Sos, Roman K. Thomas, Stefanie Fischer et al.|Proceedings of the National Academy of Sciences|2009Cited by 255
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumorsDennis Plenker, Martin L. Sos, M Riedel et al.|Science Translational Medicine|2017Cited by 64